Shiseido manufacturing
This article was originally published in The Rose Sheet
Executive Summary
Japanese cosmetics maker announces plan to close two cosmetic manufacturing facilities in Maizuru and Itabashi, Japan. Closings are scheduled tentatively for June 2006 and reflect ongoing supply chain innovations. Maizuru closure follows facility's inability to take advantage of Shiseido's factory automation equipment, while the Itabashi factory will close because of suburban growth, firm says. Operations will be relocated to additional four facilities. Impact on profits and losses is expected to be minimal in fiscal 2004 and 2005...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.